Abiopharma

Welltower Board of Directors Approves 15% Increase in Quarterly Dividend to $0.85 per Share

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

Local Bounti Named as Exclusive CEA Honoree on the TIME Worlds Growth Leaders 2026 List

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

HONEYWELL TO HOST 2026 UPDATE CALL AND INTRODUCE OUTLOOK FOR HONEYWELL TECHNOLOGIES (REMAINCO) ON MONDAY, JUNE 8

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Q.E.P. Co., Inc. Reports Fiscal 2026 Full Year Financial Results